Back
Metagenomi Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
MGX
Metagenomi Therapeutics, Inc.
Last Price:
$1.46
Seasonality Move:
-34.72%
7 Day Trial
ALL ACCESS PASS
$
7
Metagenomi Therapeutics, Inc. Stock Forecast
-
Is Metagenomi Therapeutics, Inc. Stock Undervalued?The current Metagenomi Therapeutics, Inc. [MGX] share price is $1.45. The Score for MGX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
MGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Metagenomi Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Metagenomi Therapeutics, Inc. Stock Rating
Data Unavailable
Metagenomi Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
metagenomi.co
52-Week Data
52-Week High:
3.95
52-Week Low:
1.23
Prediction Charts
Market Cap:
54.4M
Price in USD:
1.45
Volume:
258.3K
Beta:
0.49
Technical Analysis
SMA50:
1.66
SMA100:
2.02
SMA200:
1.92
52-Wk Change:
-39.33%
Stock Predictions
-
Is Metagenomi Therapeutics, Inc. stock public?Yes, Metagenomi Therapeutics, Inc. is a publicly traded company.
-
What is the Metagenomi Therapeutics, Inc. stock quote today?The Metagenomi Therapeutics, Inc. stock price is 1.45 USD today.
-
How to buy Metagenomi Therapeutics, Inc. stock online?You can buy Metagenomi Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-26 | 1.70 | 1.67 | 1.70 | 1.64 |
| Jan-27 | 1.68 | 1.66 | 1.69 | 1.64 |
| Jan-28 | 1.67 | 1.60 | 1.68 | 1.60 |
| Jan-29 | 1.60 | 1.58 | 1.61 | 1.57 |
| Jan-30 | 1.57 | 1.54 | 1.59 | 1.53 |
| Feb-2 | 1.53 | 1.54 | 1.56 | 1.52 |
| Feb-3 | 1.54 | 1.49 | 1.56 | 1.46 |
| Feb-4 | 1.49 | 1.45 | 1.50 | 1.44 |
| Feb-5 | 1.45 | 1.41 | 1.57 | 1.40 |
| Feb-6 | 1.46 | 1.54 | 1.55 | 1.39 |
| Feb-9 | 1.54 | 1.53 | 1.55 | 1.45 |
| Feb-10 | 1.53 | 1.57 | 1.59 | 1.52 |
| Feb-11 | 1.58 | 1.52 | 1.59 | 1.49 |
| Feb-12 | 1.52 | 1.45 | 1.54 | 1.44 |
Metagenomi Therapeutics, Inc. Earnings
Data Unavailable
Metagenomi Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.37 per share.
* Metagenomi Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.